Whyalla steelworks was ‘relying on luck for safety’ before administration

The Whyalla steelworks was losing $1.5 million per day before being forced into administration, burning through nearly $320 million in seven months, administrators KordaMentha revealed at a creditors meeting on Monday. The administrators outlined total debts exceeding $1.34 billion, including $189 million in outstanding employee entitlements and $40.2 million owed to the South Australian government…

BlueScope, BHP and Rio Tinto select Kwinana for 40,000 tpa green iron pilot plant

Steelmaker BlueScope and iron ore miners, BHP and Rio Tinto have selected Kwinana Industrial Area, south of Perth, to host an electric smelting furnace pilot plant, which aims to test and optimise lower-carbon emissions molten iron from Pilbara iron ore using direct reduced iron (DRI)-ESF technology.  Rio said the trio assessed a number of locations…

HLTCRC maps out heavy industry net zero transition

The Heavy Industry Low-Carbon Transition Co-operative Research Centre (HILT CRC) has launched a flagship three-year project on energy infrastructure to help guide heavy industry decarbonisation. The project will provide clear, data-driven estimates of energy costs to inform government policy and enable heavy industry to plan its decarbonisation pathway. ‘Unlocking investment in energy infrastructure for net-zero…

Australia won’t have ‘green steel’ to itself. Africa is poised to become a global hub

By Charlie Huang, RMIT University Australia is at the forefront of efforts to turn steelmaking green. Earlier this year Australian iron ore producers Rio Tinto teamed up with Australian steelmaker BlueScope to develop “near-zero emission-intensity” pathways for making steel from Pilbara iron ore. Renewable electricity and hydrogen would replace coking coal. Iron ore miner Fortescue…

Manufacturing news briefs – stories you might have missed

IDT Australia secures Sanofi contract Pharmaceutical development company IDT Australia has secured a follow on contract with pharma giant Sanofi Australia for preclinical formulation, development and manufacture of Sanofi’s messenger RNA (mRNA). The contract, worth up to $4 million, continues the company’s advancement of mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables…